Kid Covid Boosters Promise Safer Schools if Parents Buy In

Jan. 5, 2022, 10:35 AM UTC

Lingering vaccine hesitancy is complicating the Biden administration’s goal to keep kids in classrooms, even with clearance of Pfizer Inc.’s booster shot for 12- to 15-year-olds, health policy analysts say.

The Food and Drug Administration kicked off 2022 by authorizing Pfizer’s Covid-19 boosters for young teens, widening access to additional doses as parents seek to protect their children from the omicron variant. Boosters have been shown to be effective against severe illness from omicron, but their ability to help scale back infections in schools may be restricted if only half of U.S. parents are getting their children vaccinated.

“I’m excited ...

Learn more about Bloomberg Law or Log In to keep reading:

Learn About Bloomberg Law

AI-powered legal analytics, workflow tools and premium legal & business news.

Already a subscriber?

Log in to keep reading or access research tools.